Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Humble protein, nanoparticles tag-team to kill cancer cells

Images of Ramos cells targeted with nanoparticles. Particles carrying human transferrin (white dots, above image and close-up insert) were able to zero in on, attach to and enter cells (grey spheres).
Images of Ramos cells targeted with nanoparticles. Particles carrying human transferrin (white dots, above image and close-up insert) were able to zero in on, attach to and enter cells (grey spheres).

Abstract:
A normally benign protein found in the human body appears to be able - when paired with nanoparticles - to zero in on and kill certain cancer cells, without having to also load those particles with chemotherapy drugs.

Humble protein, nanoparticles tag-team to kill cancer cells

Chapel Hill, NC | Posted on August 3rd, 2010

The finding could lead to a new strategy for targeted cancer therapies, according to the University of North Carolina at Chapel Hill scientists who made the discovery.

However, they also cautioned that the result raises concerns about unanticipated "off-target" effects when designing nano-delivery agents.

Transferrin, the fourth most abundant protein in human blood, has been used as a tumor-targeting agent for delivering cancer drugs for almost two decades. The protein's receptor is over-expressed on the surface of many rapidly growing cancers cells, so treatments combined with transferrin ligands are able to seek out and bind to them. Nanoparticles infused with transferrin have long been regarded as safe and nontoxic.

Now, UNC researchers have shown that, surprisingly, attaching transferrin to a nanoparticle surface can effectively and selectively target and kill B-cell lymphoma cells, found in an aggressive form of non-Hodgkin's lymphoma. It had been thought that nanoparticles would also need to carry toxic chemotherapy agents to have such an effect.

The discovery was made by a team of researchers led by Joseph DeSimone, Ph.D., Chancellor's Eminent Professor of Chemistry in UNC's College of Arts and Sciences and William R. Kenan Jr. Distinguished Professor of Chemical Engineering at North Carolina State University, along with Jin Wang, Ph.D., and Shaomin Tian, Ph.D., in DeSimone's lab. Their findings appear in this week's online issue of the Journal of the American Chemical Society.

The scientists say the result is an interesting development in the field of nanomedicine, which researchers hope will eventually provide widely accepted alternatives - or replacements - to chemo and radiation treatment. Those therapies, while considered the most effective methods currently available for tackling cancer, also often damage healthy tissues and organs as a side effect.

Using PRINT (Particle Replication in Non-wetting Templates) technology — a technique invented in DeSimone's lab that allows scientists to produce nanoparticles with well-defined size and shape — the UNC researchers produced biocompatible nanoparticles bonded with human transferrin, and demonstrated that the particles can safely and accurately recognize a broad spectrum of cancers. As well as B-cell lymphoma cells, the particles also effectively targeted non-small cell lung, ovarian, liver and prostate cancer cells.

Generally, the nanoparticles were non-toxic to such cells and should therefore be able to be loaded with standard chemotherapy agents and used to hone in on those cancers.

However, for Ramos cells, an aggressive form of B-cell lymphoma, the transferrin-bonded PRINT nanoparticles not only recognized them but also induced cell death. Meanwhile, free transferrin - which was incubated with Ramos cells but not bound to any nanoparticles - did not kill any Ramos cells, even at high concentrations.

Researchers are carrying out further studies to determine how and why the transferrin-carrying nanoparticles proved toxic to the Ramos cells but not the other tumor types.

"Although this is potentially exciting for the development of entirely new strategies for treating certain types of lymphomas with potentially lower side effects, this study also raises concerns for unanticipated off-target effects when one is designing targeted chemotherapy agents for other types of cancers," said DeSimone. DeSimone is also a member of UNC's Lineberger Comprehensive Cancer Center and the co-principal investigator for the Carolina Center for Cancer Nanotechnology Excellence. He was also recently appointed as an adjunct member at New York's Memorial Sloan-Kettering Cancer Center.

Other UNC coauthors were Robby A. Petros, Ph.D., and Mary E. Napier, Ph.D., from the chemistry department and the Carolina Center for Cancer Nanotechnology Excellence.

The study, "The Complex Role of Multivalency in Nanoparticles Targeting the Transferrin Receptor for Cancer Therapies," was funded by the National Science Foundation; the National Institutes for Health; the Carolina Center for Cancer Nanotechnology Excellence; the William R. Kenan Professorship; Liquidia Technologies; and the North Carolina University Cancer Research Fund, established by the N.C General Assembly to help prevent and treat cancer across the state.

####

For more information, please click here

Contacts:
News Services contact:
Patric Lane
(919) 962-8596

Copyright © University of North Carolina at Chapel Hill

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nitrogen Doped Graphene Characterized by Iranian, Russian, German Scientists October 21st, 2014

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Physicists build reversible laser tractor beam October 20th, 2014

Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014

Govt.-Legislation/Regulation/Funding/Policy

Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014

Imaging electric charge propagating along microbial nanowires October 20th, 2014

HP Supercomputer at NREL Garners Top Honor October 19th, 2014

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

Possible Futures

Imaging electric charge propagating along microbial nanowires October 20th, 2014

Superconducting circuits, simplified: New circuit design could unlock the power of experimental superconducting computer chips October 18th, 2014

Nanocoatings Market By Product Is Expected To Reach USD 8.17 Billion By 2020: Grand View Research, Inc. October 15th, 2014

Perpetuus Carbon Group Receives Independent Verification of its Production Capacity for Graphenes at 140 Tonnes per Annum: Perpetuus Becomes the First Manufacturer in the Sector to Allow Third Party Audit October 7th, 2014

Academic/Education

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

Raytheon, UMass Lowell open on-campus research institute: Industry leader’s researchers to collaborate with faculty, students to move key technologies forward through first-of-its-kind partnership October 11th, 2014

SUNY Colleges of Nanoscale Science and Engineering and National Institute for Occupational Safety and Health Announce Expanded Partnership October 2nd, 2014

Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Nanomedicine

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

Tuning light to kill deep cancer tumors: Nanoparticles developed at UMass Medical School advance potential clinical application for photodynamic therapy October 15th, 2014

Announcements

Nitrogen Doped Graphene Characterized by Iranian, Russian, German Scientists October 21st, 2014

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Physicists build reversible laser tractor beam October 20th, 2014

Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014

Nanobiotechnology

Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014

Scientists Map Key Moment in Assembly of DNA-Splitting Molecular Machine: Crucial steps and surprising structures revealed in the genesis of the enzyme that divides the DNA double helix during cell replication October 15th, 2014

DNA nano-foundries cast custom-shaped metal nanoparticles: DNA's programmable assembly is leveraged to form precise 3D nanomaterials for disease detection, environmental testing, electronics and beyond October 10th, 2014

Charged graphene gives DNA a stage to perform molecular gymnastics October 9th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE